- Home
- SOND vs CALC Comparison
SOND vs CALC Comparison
Compare SOND & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- CALC
- Stock Information
- Founded
- SOND 2014
- CALC 2011
- Country
- SOND United States
- CALC United States
- Employees
- SOND N/A
- CALC N/A
- Industry
- SOND Hotels/Resorts
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- CALC Health Care
- Exchange
- SOND Nasdaq
- CALC Nasdaq
- Market Cap
- SOND 25.8M
- CALC 20.9M
- IPO Year
- SOND N/A
- CALC N/A
- Fundamental
- Price
- SOND $2.11
- CALC $1.91
- Analyst Decision
- SOND
- CALC Strong Buy
- Analyst Count
- SOND 0
- CALC 3
- Target Price
- SOND N/A
- CALC $16.33
- AVG Volume (30 Days)
- SOND 15.9K
- CALC 33.2K
- Earning Date
- SOND 05-20-2025
- CALC 05-14-2025
- Dividend Yield
- SOND N/A
- CALC N/A
- EPS Growth
- SOND N/A
- CALC N/A
- EPS
- SOND N/A
- CALC N/A
- Revenue
- SOND $624,458,000.00
- CALC N/A
- Revenue This Year
- SOND $28.50
- CALC N/A
- Revenue Next Year
- SOND $17.62
- CALC N/A
- P/E Ratio
- SOND N/A
- CALC N/A
- Revenue Growth
- SOND 8.32
- CALC N/A
- 52 Week Low
- SOND $0.88
- CALC $1.43
- 52 Week High
- SOND $10.50
- CALC $6.02
- Technical
- Relative Strength Index (RSI)
- SOND 43.26
- CALC 56.52
- Support Level
- SOND $2.13
- CALC $1.86
- Resistance Level
- SOND $2.38
- CALC $2.04
- Average True Range (ATR)
- SOND 0.14
- CALC 0.14
- MACD
- SOND -0.01
- CALC 0.05
- Stochastic Oscillator
- SOND 9.84
- CALC 64.79
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.